18don MSN
Rallybio shares successful early-stage results for rare disease drug; new trial set for late 2026
Rallybio Corporation RLYB on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of RLYB116 for complement-mediated diseases, with its initial ...
A new study published in Science suggests a single nasal spray vaccine may protect against colds, flu, bacterial lung ...
4. Time: Rush to hospital, as every minute saves brain cells.
Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...
Read more about Nanoparticle and AI-driven vaccines target broad protection against emerging threats on Devdiscourse ...
Morning Overview on MSN
Universal nasal spray vaccine could block COVID, flu, and pneumonia
Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...
Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...
Lower Sugar Intake in Infancy Linked to Fewer Adult Heart Attacks: StudyLimiting sugar intake from pregnancy through the ...
Korea Research Institute of Bioscience and Biotechnology has reported that a pharmaceutical excipient can prime innate immunity and deliver complete survival in mouse models exposed to ...
Quadruple attenuated intracellular Listeria has demonstrated safety and potency in preclinical studies and is set to enter ...
Innate immune sensors—known as pattern recognition receptors (PRRs)—detect specific molecular components of bacterial or ...
Supplements, surprising treatments, immunity-boosting vaccines and even exercises can help the immune system do its job ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results